🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 155 of 200 · A–Z by INN

  1. quinidine sulfate

    QUINIDINE SULFATE BICYCLE THERAPEUTICS

    ORAL FDA: approved

  2. quinine

    QUINATE Lacuna Pharma Pty Ltd

    TGA: approved

  3. quinine sulfate

    QUININE SULFATE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  4. quinupristin

    SYNERCID

    INJECTION FDA: approved

  5. quizartinib

    VANFLYTA

    EMA: approved

    L01EX11

  6. quizartinib dihydrochloride

    VANFLYTA

    ORAL FDA: approved

  7. quizartinib hydrochloride

    VANFLYTA

    PMDA: approved

  8. rabeprazole

    APO-RABEPRAZOLE Alphapharm Pty Ltd

    TGA: approved · NMPA: clinical trials

  9. rabeprazole sodium

    RABEPRAZOLE SODIUM Amneal Pharma Europe Ltd

    ORAL FDA: approved

  10. rad001

    NMPA: clinical trials

  11. radamts13

    ADZYNMA Takeda

    EMA: approved

    B01AD13

  12. radiation

    NMPA: clinical trials

  13. radium ra-223 dichloride

    XOFIGO

    INTRAVENOUS FDA: approved

  14. radium ra223 dichloride

    XOFIGO

    EMA: approved

    V10XX03

  15. raloxifene

    EVISTA Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    G03XC01

  16. raloxifene hydrochloride

    RALOXIFENE HYDROCHLORIDE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  17. raltegravir

    ISENTRESS Merck KGaA, Darmstadt, Germany

    EMA: approved · TGA: approved

    J05AJ01

  18. raltegravir potassium

    RALTEGRAVIR VIATRIS

    ORAL FDA: approved · EMA: application withdrawn · PMDA: approved

    J05AJ01

  19. raltitrexed

    TOMUDEX Pfizer Australia Pty Ltd

    TGA: approved · NMPA: clinical trials

  20. ramelteon

    ROZEREM Takeda

    ORAL FDA: approved · PMDA: approved

  21. ramipril

    APO-RAMIPRIL Alphapharm Pty Ltd

    ORAL FDA: approved · TGA: approved

  22. ramipril + felodipine

    TRIASYN 5.0/5.0 Sanofi-aventis Healthcare Pty Ltd

    TGA: approved

  23. ramosetron hydrochloride

    IRRIBOW

    PMDA: approved

  24. ramucirumab

    CYRAMZA

    INJECTION FDA: approved · EMA: approved · PMDA: approved

    L01FX06

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources